Subclinical doses are improving peoples lives by eliminating the physical symptoms of inflammation that previously elicited a looks like youll have to live with it response from doctors
They stimulate insulin secretion, inhibit glucagon release, and slow gastric emptying, which aids in lowering blood sugar levels and promotes satiety
doi: 10.1161/ATVBAHA.115.305380 117 KnudsenLBLauJ
Extracellular matrix remodeling in chronic liver disease
GLP-1 has been shown to: Improve mitochondrial function Support insulin sensitivity Reduce oxidative stress Potentially decrease the risk of atherosclerosis Support cardiovascular health Potentially lower the risk of Alzheimers dementia These broader metabolic and cellular benefits are part of why GLP-1 therapy has gained significant attention in the medical community
In the SURPASS-4 trial, adults with T2DM at heightened cardiovascular risk, who were inadequately managed with oral glucose-lowering agents, once-weekly tirzepatide (5 mg, 10 mg, or 15 mg) were compared to insulin glargine (100 U/mL)